Financhill
Back

Cullinan Therapeutics Quote, Financials, Valuation and Earnings

Cullinan Therapeutics Price Quote

$15.66
-0.58 (-3.57%)
(Updated: October 31, 2024 at 6:55 PM ET)

Cullinan Therapeutics Key Stats

Sell
31
Cullinan Therapeutics (CGEM) is a Sell

Day range:
$16.20 - $16.79
52-week range:
$7.64 - $30.19
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
1.49%

Volume:
165.3K
Avg. volume:
525.6K
1-year change:
86.88%
Market cap:
$979.8M
Revenue:
$0
EPS:
$-3.06

How Much Does Cullinan Therapeutics Make?

Data Unavailable

Is Cullinan Therapeutics Growing As A Company?

Data Unavailable

Cullinan Therapeutics Stock Price Performance

What Is Cullinan Therapeutics 52-Week High & Low?

Cullinan Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Cullinan Therapeutics?

Is Cullinan Therapeutics Cash Flow Positive?

  • What Is CGEM Cash Flow From Operations?
    Cash flow from operations (TTM) is -$126.8M
  • What Is Cullinan Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $263.6M
  • What Is Cullinan Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$163.6M

Cullinan Therapeutics Return On Invested Capital

Data Unavailable

Cullinan Therapeutics Earnings Date & Stock Price

Cullinan Therapeutics Competitors

Cullinan Therapeutics Dividend Yield

Cullinan Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -2.34%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 8
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 32.22
Upside from Last Price: 98.41%

Major Shareholders

  • How many CGEM shares are owned by institutional investors?
    85.3M CGEM shares are owned by institutional investors
  • How many CGEM shares are owned by insiders?
    2.7M CGEM shares are owned by insiders